Otsuka Holdings Co Ltd 4578
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- JPY 6,561.00
- Day Range
- JPY 6,342.00–6,499.00
- 52-Week Range
- JPY 4,652.00–6,845.00
- Bid/Ask
- JPY 6,354.00 / JPY 6,382.00
- Market Cap
- JPY 3.46 Tril
- Volume/Avg
- 1.3 Mil / 1.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 14.59
- Price/Sales
- 1.70
- Dividend Yield (Trailing)
- 1.68%
- Dividend Yield (Forward)
- 1.83%
- Total Yield
- 1.63%
Company Profile
Otsuka Holdings Co Ltd is a Japan-based company operates in pharmaceuticals, nutraceuticals and consumer products. Business activity of the company includes providing healthcare solutions in the areas of nervous system, oncology, cardiovascular system, respiratory system, infectious disease and others. It is also engaged in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks and dietary food. In addition it also operates multiple businesses related to chemicals, transportation, warehousing, and electronic equipment. Geographically, it operates in Japan, North America and in other regions of which Japan accounts for larger share of revenue.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Core
- Total Number of Employees
- 39,548
- Website
- http://www.otsuka.com/jp
Comparables
Valuation
|
Metric
|
4578
|
4554
|
2929
|
|---|---|---|---|
Price/Earnings (Normalized) | 14.59 | 7.72 | 5.12 |
Price/Book Value | 1.42 | 0.92 | 2.57 |
Price/Sales | 1.70 | 0.93 | 0.37 |
Price/Cash Flow | 11.14 | 3.99 | 4.14 |
Price/Earnings
4578
4554
2929
Financial Strength
|
Metric
|
4578
|
4554
|
2929
|
|---|---|---|---|
Quick Ratio | 1.53 | 0.68 | 0.80 |
Current Ratio | 2.07 | 1.46 | 1.07 |
Interest Coverage | 21.07 | 55.27 | 116.29 |
Quick Ratio
4578
4554
2929
Profitability
|
Metric
|
4578
|
4554
|
2929
|
|---|---|---|---|
Return on Assets (Normalized) | 8.73% | 3.39% | 16.62% |
Return on Equity (Normalized) | 12.03% | 7.02% | 71.66% |
Return on Invested Capital (Normalized) | 10.68% | 4.22% | 21.06% |
Return on Assets
4578
4554
2929
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Yrsgzzngsn | Yjl | $718.4 Bil | |
JNJ
| Johnson & Johnson | Fcqlfzpb | Fsqm | $360.8 Bil | |
MRK
| Merck & Co Inc | Pxlpwqch | Frls | $326.3 Bil | |
ABBV
| AbbVie Inc | Tmwpvcsb | Vbsf | $286.3 Bil | |
AZN
| AstraZeneca PLC ADR | Ryfypqlp | Ptqzt | $235.6 Bil | |
NVS
| Novartis AG ADR | Chdrwyls | Mzqt | $197.6 Bil | |
RHHBY
| Roche Holding AG ADR | Dxlqmsyft | Pdqr | $193.6 Bil | |
PFE
| Pfizer Inc | Hzkjbdvqb | Xvwrs | $153.9 Bil | |
AMGN
| Amgen Inc | Zmvvprhryw | Nwmv | $149.3 Bil | |
SNY
| Sanofi SA ADR | Dxlflklr | Cspp | $123.9 Bil |